摘要:
Provide herein is a substantially pure Lys-gingipain complex preparation, Lys-gingipain being characterized as having an apparent molecular mass of 105 kDa as estimated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, where sample is prepared without boiling, said Lys-gingipain having amidolytic and proteolytic activity for cleavage after lysine residues and having no amidolytic and/or proteolytic activity for cleavage after arginine residues, wherein the amidolytic and/or proteolytic activity is inhibited by TLCK, cysteine protease group-specific inhibitors including iodoacetamide and iodoacetic acid, wherein the amidolytic and/or proteolytic activity of said Lys-gingipain is not sensitive to inhibition by leupeptin, antipain, trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane, serine protease group-specific inhibitors including diisopropylfluorophosphate and phenylmethyl sulfonylfluoride, and antibodies specific for the Lys-gingipain protein complex and its catalytic component, methods for preparation. As specifically exemplified, a Lys-gingipain protein complex is purified from Porphyromonas gingivalis H66, and the 60 kDa catalytic component of the Lys-gingipain protein complex has an amino acid sequence as given in SEQ ID NO: 14 from amino acid 1 through amino acid 509. Also provided are nucleic acid sequences encoding this catalytic protein. The nucleotide coding sequence of the 60 kDa catalytic component of the Lys-gingipain protein complex is given in SEQ ID NO:13, from nucleotide 1336 through nucleotide 2863. The Lys-gingipain complex also comprises a hemagglutinin component identified by an N-terminal amino acid sequence as given in SEQ ID NO:14, amino acids 510-714.
摘要翻译:本文提供了一种基本上纯的赖氨酸蛋白糊精复合物制剂,其特征在于具有105kDa的表观分子量,通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳测定,其中样品在不沸腾的情况下制备,所述Lys-盖蛋白具有酰胺分解和 在赖氨酸残基之后切割的蛋白水解活性,并且在精氨酸残基之后没有用于切割的酰胺解和/或蛋白水解活性,其中所述酰胺分解和/或蛋白水解活性被TLCK抑制,包括碘乙酰胺和碘乙酸的半胱氨酸蛋白酶组特异性抑制剂,其中酰胺分解 所述Lys-gingipain的蛋白水解和/或蛋白水解活性对亮抑酶肽,抗胰蛋白酶,反式环氧琥珀酰基-L-亮氨酰氨基 - (4-胍基)丁烷,丝氨酸蛋白酶组特异性抑制剂,包括二异丙基氟磷酸酯和苯基甲基磺酰氟的抑制和抗体特异性 用于Lys-gingipain蛋白复合物及其催化 组分,制备方法。 如具体示例的那样,从牙龈卟啉单胞菌H66中纯化Lys-gingipain蛋白复合物,Lys-gingipain蛋白复合物的60kDa催化组分具有SEQ ID NO:14中从氨基酸1到氨基酸所给出的氨基酸序列 还提供了编码该催化蛋白的核酸序列。 Lys-gingipain蛋白质复合物的60kDa催化组分的核苷酸编码序列在SEQ ID NO:13中由核苷酸1336至核苷酸2863给出。Lys-gingipain复合物还包含由N-末端氨基酸鉴定的血凝素成分 酸序列,如SEQ ID NO:14所示,氨基酸510-714。
摘要:
A miniaturized antenna system is characterized non-destructively through the use of a scanner that measures its near-field radiated power performance. When taking measurements, the scanner can be moved linearly along the x, y and z axis, as well as rotationally relative to the antenna. The data obtained from the characterization are processed to determine the far-field properties of the system and to optimize the system. Each antenna is excited using a probe station system while a scanning probe scans the space above the antenna to measure the near field signals. Upon completion of the scan, the near-field patterns are transformed into far-field patterns. Along with taking data, this system also allows for extensive graphing and analysis of both the near-field and far-field data. The details of the probe station as well as the procedures for setting up a test, conducting a test, and analyzing the resulting data are also described.
摘要:
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome, for expression of polypeptides and use of the polypeptides to prepare antibodies, where both the polypeptides and antibodies may be employed as diagnostic reagents or in therapy, e.g., vaccines and passive immunization. The sequences provide detection of the viral infectious agents associated with the indicated syndromes and can be used for expression of antigenic polypeptides.
摘要:
The present invention provides a method of screening for a biological modifier that modulates apoptosis-induced cell death by contacting a cell expressing CDN-1 or fragments or variants thereof with a potential biological modifier and measuring the level of apoptosis-induced cell death induced thereby.
摘要:
Methods and compositions are provided for producing, in yeast, basic and acidic fibroblast growth factors (FGF's) that are at least partially acetylated at their amino-termini. DNA constructs containing genes coding for the FGF polypeptides under transcriptional control of a regulatable promoter are expressed in transformed host yeast cells to achieve high yields of the processed FGF's.
摘要:
The invention provides soluble forms of the Fas (Apo-1) protein comprising both the intracellular and extracellular domains of the full-length polypeptide. Exemplified is a naturally-occurring splice variant of the Fas gene, Fas.DELTA.TM, which lacks the transmembrane domain of the native antigen. DNA encoding the protein, cells expressing the recombinant DNA, and methods of using the protein and DNA are also provided.
摘要:
The present invention is directed to methods of obtaining plant-derived delipidated extracts that inhibit apoptosis, the extracts obtained, compositions containing said extracts and methods of using said compositions. FIG. 11 is a bar graph which illustrates a lower incidence of diarrhea in rats treated with methotrexate and fed a diet of compositions of the claimed invention as compared to controls.
摘要:
The novel substance E-5-(2-bromovinyl)-2'-deoxyuridine and its corresponding iodovinyl derivative are gifted with specific antiviral activities towards herpes simplex virus. They may be synthesized by a condensation reaction followed by separation of anomers.
摘要:
The present invention provides polynucleotide sequences (bbp) encoding a Bak Binding Protein (BBP) and fragments thereof that bind to Bak. The invention also provides a BBP which binds to Bak. The invention also provides recombinant host cells containing polynucleotides encoding BBP. The invention further provides antibodies that specifically bind to BBP. The invention further provides methods for detecting agents such as drugs that alter the binding of a BBP with a Bak protein. The invention further provides methods for detecting the presence of bbp or BBP in a biological sample, and further provides methods for modulating the levels of BBP in a cell. This invention additionally encompasses novel peptides, designated the “BBP Binding Domains” and the respective nucleotides, designated “bbpbd-1” and “bbpbd-2” which are involved in the interaction between Bak and BBP.